IHF:NYE-iShares U.S. Healthcare Providers ETF (USD)

ETF | Health |

Last Closing

USD 47.42

Change

+0.03 (+0.06)%

Market Cap

N/A

Volume

0.20M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-06-05 )

Largest Industry Peers for Health

Symbol Name Price(Change) Market Cap
XLV Health Care Select Sector SPDR..

-0.18 (-0.14%)

USD 33.98B
FHLC Fidelity® MSCI Health Care In..

-0.05 (-0.08%)

USD 2.37B
FXH First Trust Health Care AlphaD..

-0.08 (-0.08%)

USD 0.90B
XHE SPDR® S&P Health Care Equipme..

+0.43 (+0.53%)

USD 0.17B
IDNA iShares Genomics Immunology an..

-0.11 (-0.53%)

USD 0.10B
XHS SPDR® S&P Health Care Service..

-0.06 (-0.06%)

USD 0.09B
SBIO ALPS Medical Breakthroughs ETF

+0.09 (+0.29%)

USD 0.08B
HTEC Robo Global® Healthcare Techn..

-0.12 (-0.44%)

USD 0.04B
BBP Virtus LifeSci Biotech Product..

+0.20 (+0.34%)

USD 0.02B
BBC Virtus LifeSci Biotech Clinica..

+0.18 (+0.91%)

USD 0.01B

ETFs Containing IHF

MSSS Northern Lights Fund Trus.. 8.93 % 0.00 %

-0.10 (-0.34%)

USD 0.09B
LCR Managed Portfolio Series 0.00 % 0.00 %

-0.05 (-0.34%)

USD 0.07B

Market Performance

  Market Performance vs. Industry/Classification (Health) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -1.19% 85% B 44% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -1.19% 85% B 41% F
Trailing 12 Months  
Capital Gain -10.36% 19% F 21% F
Dividend Return 0.58% 56% F 9% A-
Total Return -9.78% 19% F 19% F
Trailing 5 Years  
Capital Gain 16.68% 52% F 48% F
Dividend Return 4.98% 63% D 11% F
Total Return 21.66% 52% F 38% F
Average Annual (5 Year Horizon)  
Capital Gain 1.83% 62% D 46% F
Dividend Return 2.48% 62% D 39% F
Total Return 0.64% 63% D 15% F
Risk Return Profile  
Volatility (Standard Deviation) 18.82% 43% F 52% F
Risk Adjusted Return 13.16% 57% F 34% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.